Feed aggregator

UPDATED Comparing COVID-19 Vaccines: Timelines, Types and Prices

Biospace news - Tue, 06/15/2021 - 02:00
As the Pfizer-BioNTech COVID-19 vaccine is being evaluated by the U.S. FDA and the Moderna vaccine is soon to follow, here’s a look at several of the top COVID-19 vaccine candidates and where they stand as of today.

Study identifies how COVID-19 linked to Alzheimer's disease-like cognitive impairment

World Pharma News - Mon, 06/14/2021 - 12:00
A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer's disease-like dementia. The findings, published in Alzheimer's Research & Therapy, indicate an overlap between COVID-19 and brain changes common in Alzheimer's, and may help inform risk management and therapeutic strategies for COVID-19-associated cognitive impairment.

Novavax COVID-19 vaccine demonstrates 90% overall efficacy and 100% protection against moderate and severe disease in PREVENT-19 Phase 3 trial

World Pharma News - Mon, 06/14/2021 - 10:00
Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its recombinant nanoparticle protein-based COVID-19 vaccine, demonstrated 100% protection against moderate and severe disease, 90.4% efficacy overall, and met the primary endpoint in its PREVENT-19 pivotal Phase 3 trial.

GSK Inks Potential $1.4 Billion Oncology Deal With Belgium-Based iTeos

Biospace news - Mon, 06/14/2021 - 02:00
Shares of iTeos Therapeutics skyrocketed more than 50% in premarket trading after it struck an agreement with GSM to co-develop and commercialize a cancer treatment.

Enochian BioSciences Aims to Advance HIV Treatment That Could Provide Functional Cure

Biospace news - Mon, 06/14/2021 - 02:00
The FDA accepted its pre-Investigational New Drug request for a cell therapy treatment that could be a key factor in controlling HIV.

EU Hits AstraZeneca Vaccine with Another Blood Condition for Side Effect List

Biospace news - Mon, 06/14/2021 - 02:00
The EMA identified a rare blood condition, capillary leak syndrome, as a potential side effect of AstraZeneca’s Vaxzevria.

Flagship Pioneering Takes Aim at Global Health Threats with $3.37 Billion Fund

Biospace news - Mon, 06/14/2021 - 02:00
​Flagship Pioneering announced a massive cash infusion to support the development and launch of new companies aiming at various diseases and global health threats.

FDA Once Again Rejects Avenue Therapeutics’ NDA for IV Non-Opioid Painkiller

Biospace news - Mon, 06/14/2021 - 02:00
The FDA stated that the unpredictable and delayed analgesia onset with the intravenous therapy could not support a benefit when given alone to manage acute pain.

Novavax’s COVID-19 Vaccine is 90.4% Effective, According to New Study Findings

Biospace news - Mon, 06/14/2021 - 02:00
The study also found the vaccine was 100% effective at preventing moderate and severe disease.

FDA Action Alert: Blueprint, Orphazyme and Eton

Biospace news - Mon, 06/14/2021 - 02:00
The month of June continues to be busy for the U.S. Food and Drug Administration. There are three PDUFA dates on the calendar for this week. Here’s a look.

Retinal Tissue Restored in Patients with Dry AMD, Heralding Paradigm Shift

Biospace news - Mon, 06/14/2021 - 02:00
Retinal tissue has been regrown in three patients with age-related macular degeneration with geographic atrophy or dry (atrophic) AMD in a Phase I/IIa study conducted by Lineage Cell Therapeutics.

Clinical Catch-Up: June 7-11

Biospace news - Mon, 06/14/2021 - 02:00
A busy week for clinical trial news as the ASCO meeting wrapped up and the European Hematology Association 2021 Virtual Congress began. Read on for more.

Study Identifies Mechanisms Underlying Cognitive Impairment in COVID-19 Long-Haulers

Biospace news - Mon, 06/14/2021 - 02:00
Investigators from the Cleveland Clinic assessed possible relationships between COVID-19 and neuroinflammation and brain microvascular injury – two hallmarks of AD.

Janssen Hits Two Phase III Marks in Hematology Presentations at EHA

Biospace news - Mon, 06/14/2021 - 02:00
​Janssen presented the Phase III Glow study for the elderly with CLL or SLL and the overall survival results from the Phase III MAIA study for patients with NDMM.

An omega-3 that's poison for tumors

World Pharma News - Fri, 06/11/2021 - 10:00
So-called "good fatty acids" are essential for human health and much sought after by those who try to eat healthily. Among the Omega-3 fatty acids, DHA or docosahexaenoic acid is crucial to brain function, vision and the regulation of inflammatory phenomena.

In addition to these virtues, DHA is also associated with a reduction in the incidence of cancer.

Vertex Falls After Announcing Key Asset for Rare Disease Will Not Advance

Biospace news - Fri, 06/11/2021 - 02:00
Shares of Vertex fell more than 13% in premarket trading after it announced that it will not advance a novel small molecule corrector of the Z-AAT protein into a Phase III study.

Could Elemental Metals Be Key to Effective Alzheimer's Treatments?

Biospace news - Fri, 06/11/2021 - 02:00
This is the first confirmation of elemental metals in human brain tissue. Researchers hope it can contribute to the ongoing Herculean task of finding a cure for Parkinson's and Alzheimer's.

G7 Leaders Pledge One Billion COVID-19 Vaccines For Nations in Need

Biospace news - Fri, 06/11/2021 - 02:00
Half of these doses will be shared by the U.S., while the U.K. has committed another 100 million shots.

EHA Updates: Companies Share Positive Data in Different Blood Disorders

Biospace news - Fri, 06/11/2021 - 02:00
The 2021 EHA is in full swing. BioSpace is rounding up several presentations from the past two days. Here are some of them.

Research Roundup: A Cognitive Clock to Measure Brain Health and More

Biospace news - Fri, 06/11/2021 - 02:00
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.